Comparison of 30-day, 90-day and in-hospital postoperative mortality for eight different cancer types von Damhuis, R. A. M., Wijnhoven, B. P. L., Plaisier, P. W., Kirkels, W. J., Kranse, R., van Lanschot, J. J.

Volltext

Total Pelvic Exenteration for Primary and Recurrent Malignancies von Ferenschild, F. T. J., Vermaas, M., Verhoef, C., Ansink, A. C., Kirkels, W. J., Eggermont, A. M. M., de Wilt, J. H. W.

Volltext

Health-Related Quality-of-Life Effects of Radical Prostatectomy and Primary Radiotherapy for Screen-Detected or Clinically Diagnosed Localized Prostate Cancer von MADALINSKA, Joanna B, ESSINK-BOT, Marie-Louise, DE KONING, Harry J, KIRKELS, Wim J, VAN DER MAAS, Paul J, SCHRÖDER, Fritz H

Volltext

Short-term effects of population-based screening for prostate cancer on health-related quality of life von ESSINK-BOT, M.-L, DE KONING, H. J, NIJS, H. G. T, KIRKELS, W. J, VAN DER MAAS, P. J, SCHRÖDER, F. H

Volltext

Total pelvic exenteration for locally advanced and locally recurrent rectal cancer in the elderly von Hagemans, J.A.W., Rothbarth, J., Kirkels, W.J., Boormans, J.L., van Meerten, E., Nuyttens, J.J.M.E., Madsen, E.V.E., Verhoef, C., Burger, J.W.A.

Volltext

Outcomes of urinary diversion after surgery for locally advanced or locally recurrent rectal cancer with complete cystectomy; ileal and colon conduit von Hagemans, J.A.W., Voogt, E.L.K., Rothbarth, J., Nieuwenhuijzen, G.A.P., Kirkels, W.J., Boormans, J.L., Koldewijn, E.L., Richardson, R., Verhoef, C., Rutten, H.J.T., Burger, J.W.A.

Volltext

Tumor characteristics and prognostic factors in two subsequent screening rounds with four-year interval within prostate cancer screening trial, ERSPC Rotterdam von van der Cruijsen-Koeter, Ingrid W., Roobol, Monique J., Wildhagen, Mark F., van der Kwast, T.H., Kirkels, W.J., Schröder, Fritz H.

Volltext

Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer von Vermaas, M, Ferenschild, F.T.J, Verhoef, C, Nuyttens, J.J.M.E, Marinelli, A.W.K.S, Wiggers, T, Kirkels, W.J, Eggermont, A.M.M, de Wilt, J.H.W

Volltext

FGFR3 and P53 characterize alternative genetic pathways in the pathogenesis of urothelial cell carcinoma von VAN RHIJN, Bas W. G, VAN DER KWAST, Theo H, VIS, André N, KIRKELS, Wim J, BOEVE, Egbert R, JÖBSIS, Adriaan C, ZWARTHOFF, Ellen C

Volltext

Validity of predictions of residual retroperitoneal mass histology in nonseminomatous testicular cancer von STEYERBERG, E. W, GERL, A, FOSSA, S. D, SLEIJFER, D. T, DE WIT, R, KIRKELS, W. J, SCHMELLER, N, CLEMM, C, HABBEMA, J. D. F, KEIZER, H. J

Volltext

Measuring Disease Specific Quality of Life in Localized Prostate Cancer: The Dutch Experience von I. J. Korfage, M.-L. Essink-Bot, J. B. Madalinska, W. J. Kirkels, Litwin, M. S., H. J. de Koning

Volltext

The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate von VAN RHIJN, Bas W. G, LURKIN, Irene, RADVANYI, Francois, KIRKELS, Wim J, VAN DER KWAST, Theodorus H, ZWARTHOFF, Ellen C

Volltext

Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ-cell tumors von LOOIJENGA, Leendert H. J, DE LEEUW, Hubert, VON LINDERN, Marieke, VALK, Peter, LAJOS, Geczy, OLAH, Edit, NESLAND, Jahn M, FOSSA, Sophie D, OOSTERHUIS, J. Wolter, VAN OORSCHOT, Monique, VAN GURP, Ruud J. H. L. M, STOOP, Hans, GILLIS, Ad J. M, DE GOUVEIA BRAZAO, Carlos A, WEBER, Rob F. A, KIRKELS, Wim J, VAN DIJK, Thamar

Volltext

Health-related quality of life in patients with screen-detected versus clinically diagnosed prostate cancer preceding primary treatment von Madalinska, J.B., Essink-Bot, M.L., de Koning, H.J., Kirkels, W.J., van der Maas, P.J., Schröder, F.H.

Volltext

Why do men refuse or attend population-based screening for prostate cancer? von Nijs, HGT, Essink-Bot, ML, DeKoning, HJ, Kirkels, WJ, Schröder, FH

Volltext

Laparoscopic versus open donor nephrectomy: ureteral complications in recipients von Lind, M.Y., Hazebroek, E.J., Kirkels, W.J., Hop, W.C.J., Weimar, W., Ijzermans, J.N.M.

Volltext

Features and preliminary results of the Dutch centre of the ERSPC (Rotterdam, the Netherlands) von Roobol, M.J., Kirkels, W.J., Schröder, F.H.

Volltext

Cervical Lymph Node Dissection for Metastatic Testicular Cancer von van Vledder, M. G., van der Hage, J. A., Kirkels, W. J., Oosterhuis, J. W., Verhoef, C., de Wilt, J. H. W.

Volltext

Trends in the curative treatment of localized prostate cancer after the introduction of prostate‐specific antigen: data from the Rotterdam Cancer Registry von Spapen, S.J.J.C., Damhuis, R.A.M., Kirkels, W.J.

Volltext

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up von Schröder, Fritz H, Prof, Hugosson, Jonas, Prof, Roobol, Monique J, PhD, Tammela, Teuvo L J, Prof, Zappa, Marco, MD, Nelen, Vera, MD, Kwiatkowski, Maciej, MD, Lujan, Marcos, MD, Määttänen, Liisa, PhD, Lilja, Hans, Prof, Denis, Louis J, Prof, Recker, Franz, Prof, Paez, Alvaro, MD, Bangma, Chris H, Prof, Carlsson, Sigrid, MD, Puliti, Donella, MSc, Villers, Arnauld, MD, Rebillard, Xavier, MD, Hakama, Matti, Prof, Stenman, Ulf-Hakan, Prof, Kujala, Paula, MD, Taari, Kimmo, MD, Aus, Gunnar, MD, Huber, Andreas, Prof, van der Kwast, Theo H, Prof, van Schaik, Ron H N, Prof, de Koning, Harry J, Prof, Moss, Sue M, Prof, Auvinen, Anssi, Prof

Volltext